BDNF and cancer: Given that non-cancer participants had much higher plasma BDNF levels than cancer patients, these findings suggest that the actual plasma BDNF levels may play a larger role than change of levels for predicting CRCI as with other clinically relevant biomarkers such as serum creatinine and potassium26.